Form 424B3 Wave Life Sciences Ltd.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
B.Riley Reiterates Buy Rating on WAVE Life Sciences (WVE)
September 25, 2024 6:24 AM EDTB.Riley analyst Madison El-Saadi reiterated a Buy rating and $11.00 price target on WAVE Life Sciences (NASDAQ: WVE).
The analyst comments "In totality, we believe results exceeded our/investor expectations (9/18 initiation) and replicated the preclinical and early clinical datasets indicative of best-in-class exon skipping profile... More
WAVE Life Sciences (WVE) no longer intends to offers ordinary shares
September 24, 2024 5:23 PM EDTWAVE Life Sciences (NASDAQ: WVE) has filed the following prospectus:
This Prospectus Supplement No. 1 supplements and amends the prospectus dated May 4, 2022 (the Prospectus), covering the offering, issuance and sale of up to a maximum aggregate offering amount of $131,974,010 (the Maximum Offering Amount) of our... More
